Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Gait symmetry in the dual task condition as a predictor of future falls among independent older adults: a 2-year longitudinal study.

Gillain S, Boutaayamou M, Schwartz C, Dardenne N, Bruyère O, Brüls O, Croisier JL, Salmon E, Reginster JY, Garraux G, Petermans J.

Aging Clin Exp Res. 2019 May 8. doi: 10.1007/s40520-019-01210-w. [Epub ahead of print]

2.

Separation and determination of alpha-synuclein monomeric and oligomeric species using two electrophoretic approaches.

Napp A, Houbart V, Demelenne A, Merville MP, Crommen J, Dumoulin M, Garraux G, Servais AC, Fillet M.

Electrophoresis. 2018 Dec;39(23):3022-3031. doi: 10.1002/elps.201800224. Epub 2018 Sep 13.

3.

Correlation between deep brain stimulation effects on freezing of gait and audio-spinal reflex.

Parmentier É, De Pasqua V, D'Ostilio K, Depierreux F, Garraux G, Maertens de Noordhout A.

Clin Neurophysiol. 2018 Oct;129(10):2083-2088. doi: 10.1016/j.clinph.2018.07.006. Epub 2018 Jul 21.

PMID:
30077869
4.

Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism.

Segovia F, Górriz JM, Ramírez J, Martínez-Murcia FJ, Levin J, Schuberth M, Brendel M, Rominger A, Bötzel K, Garraux G, Phillips C.

Front Neuroinform. 2017 Mar 30;11:23. doi: 10.3389/fninf.2017.00023. eCollection 2017.

5.

Comparative assessment of 6-[18 F]fluoro-L-m-tyrosine and 6-[18 F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model.

Becker G, Bahri MA, Michel A, Hustadt F, Garraux G, Luxen A, Lemaire C, Plenevaux A.

J Neurochem. 2017 May;141(4):626-635. doi: 10.1111/jnc.14016. Epub 2017 Apr 12.

6.

Data set of healthy old people assessed for three walking conditions using accelerometric and opto-electronic methods.

Gillain S, Boutaayamou M, Dardenne N, Schwartz C, Demonceau M, Gerontitis C, Depierreux F, Salmon E, Garraux G, Bruyère O, Brüls O, Croisier JL, Petermans J.

Aging Clin Exp Res. 2017 Dec;29(6):1201-1209. doi: 10.1007/s40520-017-0730-y. Epub 2017 Feb 28.

7.

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.

Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, Crosiers D, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium.

Neurobiol Aging. 2017 Jan;49:217.e1-217.e4. doi: 10.1016/j.neurobiolaging.2016.09.022. Epub 2016 Oct 6.

8.

Contribution of four lifelong factors of cognitive reserve on late cognition in normal aging and Parkinson's disease.

Rouillard M, Audiffren M, Albinet C, Ali Bahri M, Garraux G, Collette F.

J Clin Exp Neuropsychol. 2017 Mar;39(2):142-162. doi: 10.1080/13803395.2016.1207755. Epub 2016 Aug 12.

PMID:
27686164
9.

Effects of twelve weeks of aerobic or strength training in addition to standard care in Parkinson's disease: a controlled study.

Demonceau M, Maquet D, Jidovtseff B, Donneau AF, Bury T, Croisier JL, Crielaard JM, Rodriguez de la Cruz C, Delvaux V, Garraux G.

Eur J Phys Rehabil Med. 2017 Apr;53(2):184-200. doi: 10.23736/S1973-9087.16.04272-6. Epub 2016 Sep 1.

10.

The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease.

D'Ostilio K, Garraux G.

Front Hum Neurosci. 2016 Apr 22;10:161. doi: 10.3389/fnhum.2016.00161. eCollection 2016. Review.

11.

Effects of 10 Hz and 20 Hz Transcranial Alternating Current Stimulation on Automatic Motor Control.

Cappon D, D'Ostilio K, Garraux G, Rothwell J, Bisiacchi P.

Brain Stimul. 2016 Jul-Aug;9(4):518-24. doi: 10.1016/j.brs.2016.01.001. Epub 2016 Mar 18.

PMID:
27038707
12.

Comment on: Hemidystonia caused by frontal cortical infarction.

Garraux G.

Acta Neurol Belg. 2016 Mar;116(1):115. doi: 10.1007/s13760-015-0557-2. Epub 2015 Nov 25. No abstract available.

13.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

14.

Contribution of a Trunk Accelerometer System to the Characterization of Gait in Patients With Mild-to-Moderate Parkinson's Disease.

Demonceau M, Donneau AF, Croisier JL, Skawiniak E, Boutaayamou M, Maquet D, Garraux G.

IEEE J Biomed Health Inform. 2015 Nov;19(6):1803-8. doi: 10.1109/JBHI.2015.2469540. Epub 2015 Aug 19.

PMID:
26292350
15.

Development and validation of an accelerometer-based method for quantifying gait events.

Boutaayamou M, Schwartz C, Stamatakis J, Denoël V, Maquet D, Forthomme B, Croisier JL, Macq B, Verly JG, Garraux G, Brüls O.

Med Eng Phys. 2015 Feb;37(2):226-32. doi: 10.1016/j.medengphy.2015.01.001. Epub 2015 Jan 21.

16.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium.

Neurology. 2014 Nov 18;83(21):1906-13. doi: 10.1212/WNL.0000000000001012. Epub 2014 Oct 17.

17.

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease.

Ziegler E, Rouillard M, André E, Coolen T, Stender J, Balteau E, Phillips C, Garraux G.

Neuroimage. 2014 Oct 1;99:498-508. doi: 10.1016/j.neuroimage.2014.06.033. Epub 2014 Jun 20.

18.

Biased binomial assessment of cross-validated estimation of classification accuracies illustrated in diagnosis predictions.

Noirhomme Q, Lesenfants D, Gomez F, Soddu A, Schrouff J, Garraux G, Luxen A, Phillips C, Laureys S.

Neuroimage Clin. 2014 Apr 13;4:687-94. doi: 10.1016/j.nicl.2014.04.004. eCollection 2014.

19.

Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.

Garraux G, Phillips C, Schrouff J, Kreisler A, Lemaire C, Degueldre C, Delcour C, Hustinx R, Luxen A, Destée A, Salmon E.

Neuroimage Clin. 2013 Jun 14;2:883-93. doi: 10.1016/j.nicl.2013.06.004. eCollection 2013.

20.

[Impulse control behaviors associated with antiparkinsonian medications].

Depierreux-Lahaye F, Crémers J, Skawiniak E, Parmentier E, Delvaux V, Garraux G.

Rev Med Liege. 2013 May-Jun;68(5-6):221-5. French.

21.

Impaired automatic and unconscious motor processes in Parkinson's disease.

D'Ostilio K, Cremers J, Delvaux V, Sadzot B, Garraux G.

Sci Rep. 2013;3:2095. doi: 10.1038/srep02095.

22.

Finger tapping clinimetric score prediction in Parkinson's disease using low-cost accelerometers.

Stamatakis J, Ambroise J, Crémers J, Sharei H, Delvaux V, Macq B, Garraux G.

Comput Intell Neurosci. 2013;2013:717853. doi: 10.1155/2013/717853. Epub 2013 Apr 16.

23.

Role of the supplementary motor area in the automatic activation of motor plans in de novo Parkinson's disease patients.

D'Ostilio K, Deville B, Cremers J, Grandjean J, Skawiniak E, Delvaux V, Garraux G.

Neurosci Res. 2013 Jul;76(3):173-7. doi: 10.1016/j.neures.2013.04.002. Epub 2013 May 1.

24.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium.

J Med Genet. 2012 Nov;49(11):721-6. doi: 10.1136/jmedgenet-2012-101155. Erratum in: J Med Genet. 2013 Mar;50(3):202.

25.

Evidence for a role of a cortico-subcortical network for automatic and unconscious motor inhibition of manual responses.

D'Ostilio K, Collette F, Phillips C, Garraux G.

PLoS One. 2012;7(10):e48007. doi: 10.1371/journal.pone.0048007. Epub 2012 Oct 24.

26.

Brain mechanisms underlying automatic and unconscious control of motor action.

D'Ostilio K, Garraux G.

Front Hum Neurosci. 2012 Sep 26;6:265. doi: 10.3389/fnhum.2012.00265. eCollection 2012.

27.

Brain activation pattern related to gait disturbances in Parkinson's disease.

Crémers J, D'Ostilio K, Stamatakis J, Delvaux V, Garraux G.

Mov Disord. 2012 Oct;27(12):1498-505. doi: 10.1002/mds.25139. Epub 2012 Sep 24.

PMID:
23008169
28.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

29.

Construction and validation of the Dynamic Parkinson Gait Scale (DYPAGS).

Crémers J, Phan Ba R, Delvaux V, Garraux G.

Parkinsonism Relat Disord. 2012 Jul;18(6):759-64. doi: 10.1016/j.parkreldis.2012.03.012. Epub 2012 Apr 17.

30.

Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.

Garraux G, Caberg JH, Vanbellinghen JF, Jamar M, Bours V, Moonen G, Dive D.

Arch Neurol. 2012 Mar;69(3):398-400. doi: 10.1001/archneurol.2011.802.

PMID:
22410449
31.

Gait feature extraction in Parkinson's disease using low-cost accelerometers.

Stamatakis J, Crémers J, Maquet D, Macq B, Garraux G.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7900-3. doi: 10.1109/IEMBS.2011.6091948.

PMID:
22256172
32.

Dissociation between unconscious motor response facilitation and conflict in medial frontal areas.

D'Ostilio K, Garraux G.

Eur J Neurosci. 2012 Jan;35(2):332-40. doi: 10.1111/j.1460-9568.2011.07941.x.

33.

Brain perfusion patterns in familial frontotemporal lobar degeneration.

Seelaar H, Papma JM, Garraux G, de Koning I, Reijs AE, Valkema R, Rozemuller AJ, Salmon E, van Swieten JC.

Neurology. 2011 Jul 26;77(4):384-92. doi: 10.1212/WNL.0b013e3182270456. Epub 2011 Jul 13.

PMID:
21753175
34.

[Dementia in Parkinson's disease: risk factors, diagnosis and treatment].

Bakay S, Bechet S, Barjona A, Delvaux V, Salmon E, Garraux G.

Rev Med Liege. 2011 Feb;66(2):75-81. French.

35.

Brain energization in response to deep brain stimulation of subthalamic nuclei in Parkinson's disease.

Garraux G, Bahri MA, Lemaire C, Degueldre C, Salmon E, Kaschten B.

J Cereb Blood Flow Metab. 2011 Jul;31(7):1612-22. doi: 10.1038/jcbfm.2011.41. Epub 2011 Apr 6.

36.

Hemispheric specialization during mental imagery of brisk walking.

Crémers J, Dessoullières A, Garraux G.

Hum Brain Mapp. 2012 Apr;33(4):873-82. doi: 10.1002/hbm.21255. Epub 2011 Mar 21.

PMID:
21425400
37.

Automatic stimulus-induced medial premotor cortex activation without perception or action.

D'Ostilio K, Garraux G.

PLoS One. 2011 Feb 2;6(2):e16613. doi: 10.1371/journal.pone.0016613.

38.

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ.

Ann Neurol. 2010 Sep;68(3):319-29. doi: 10.1002/ana.22068.

PMID:
20687209
39.

[Treatment of early Parkinson's disease].

Delvaux V, Moonen G, Garraux G.

Rev Med Liege. 2009 Apr;64(4):228-32. French.

40.

Gesture subtype-dependent left lateralization of praxis planning: an event-related fMRI study.

Bohlhalter S, Hattori N, Wheaton L, Fridman E, Shamim EA, Garraux G, Hallett M.

Cereb Cortex. 2009 Jun;19(6):1256-62. doi: 10.1093/cercor/bhn168. Epub 2008 Sep 16.

41.

[Preserve brain function...through physical exercice?].

Garraux G.

Rev Med Liege. 2008 May-Jun;63(5-6):293-8. French.

42.

Functional imaging of cognition in Alzheimer's disease using positron emission tomography.

Salmon E, Lekeu F, Bastin C, Garraux G, Collette F.

Neuropsychologia. 2008;46(6):1613-23. doi: 10.1016/j.neuropsychologia.2007.11.022. Epub 2007 Dec 3. Review.

PMID:
18191961
43.

Task-related interaction between basal ganglia and cortical dopamine release.

Garraux G, Peigneux P, Carson RE, Hallett M.

J Neurosci. 2007 Dec 26;27(52):14434-41.

44.

[Therapeutic armamentarium in neurology: the birth of a new era].

Belachew S, Magis D, Lievens I, Cuvelier ML, Rikir E, Garraux G, Hotermans C, Salmon E, Sadzot B, Cambron L, Maquet P, Poirrier R, Moonen G.

Rev Med Liege. 2007 May-Jun;62(5-6):432-48. Review. French.

45.

Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome.

Lerner A, Bagic A, Boudreau EA, Hanakawa T, Pagan F, Mari Z, Bara-Jimenez W, Aksu M, Garraux G, Simmons JM, Sato S, Murphy DL, Hallett M.

Neurology. 2007 Jun 5;68(23):1979-87.

PMID:
17548547
46.

Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease.

Salmon E, Lekeu F, Garraux G, Guillaume B, Magis D, Luxen A, Moonen G, Collette F.

Neurobiol Aging. 2008 Dec;29(12):1823-9. Epub 2007 May 31.

PMID:
17543421
47.

Levodopa increases memory encoding and dopamine release in the striatum in the elderly.

Floel A, Garraux G, Xu B, Breitenstein C, Knecht S, Herscovitch P, Cohen LG.

Neurobiol Aging. 2008 Feb;29(2):267-79. Epub 2006 Nov 13.

48.

Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study.

Bohlhalter S, Goldfine A, Matteson S, Garraux G, Hanakawa T, Kansaku K, Wurzman R, Hallett M.

Brain. 2006 Aug;129(Pt 8):2029-37. Epub 2006 Mar 6.

PMID:
16520330
49.

Neural correlates of counting of sequential sensory and motor events in the human brain.

Kansaku K, Johnson A, Grillon ML, Garraux G, Sadato N, Hallett M.

Neuroimage. 2006 Jun;31(2):649-60. Epub 2006 Feb 3.

PMID:
16460961
50.

Increased midbrain gray matter in Tourette's syndrome.

Garraux G, Goldfine A, Bohlhalter S, Lerner A, Hanakawa T, Hallett M.

Ann Neurol. 2006 Feb;59(2):381-5.

PMID:
16437578

Supplemental Content

Loading ...
Support Center